Background Oral anticoagulation (OAC) effectively reduces stroke risk in patients with atrial fibrillation (AF), but its use ...

Background Smoking is a significant risk factor for neurological disorders, yet its global impact on these conditions remains underexplored. Methods Using Global Burden of Diseases 2021 data, we ...

Background Amyotrophic lateral sclerosis (ALS) is a progressive and usually fatal neurodegenerative disease. Survival from diagnosis varies considerably. Several prognostic factors are known, ...

A peer-reviewed neurology, neurosurgery and psychiatry journal publishing the latest research and reviews on the entire genre of neurological sciences.

Correspondence to Dr Jonathan M Schott, Dementia Research Centre, National Hospital for Neurology and Neurosurgery, Institute of Neurology, Queen Square, Box 16, London WC1N 3BG, UK; ...

2 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA 3 Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA 4 Department of ...

Background A few case reports have shown controversial results of rituximab efficacy in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Objective To analyse the ...

Correspondence to Hanneke Frederica Maria Rhodius-Meester, Alzheimer Center, VU University Medical Center, Amsterdam 1007 MB, The Netherlands; h.rhodius{at}vumc.nl Patients with dementia have a ...

Background Staging of disease severity is useful for prognosis, decision-making and resource planning. However, no commonly used, validated staging system exists for amyotrophic lateral sclerosis (ALS ...

1 MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK 2 The Graham Watts Laboratories for Research into Motor Neuron Disease, Sobell Department of Motor Neuroscience and ...

4 Institute of Cardiovascular and Cell Sciences, St Georges University of London, London, UK 5 School of Health Professions, Peninsula Allied Health Centre, University of Plymouth, Plymouth, UK ...

Objectives Chronic inflammatory axonal polyneuropathy (CIAP) is defined on the basis of the clinical, electrophysiological and nerve biopsy findings and therapeutic responses of ‘immunotherapy ...